Matches in Nanopublications for { ?s ?p "[The results from this study suggest, however, that the expression of survivin, survivin-deltaEx3, survivin-2B, bag-1, galectin-3, bax-alpha and MRP-1 mRNAs cannot be considered as prognostic indicators of disease outcome for patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP419867.RAAn_ry4RWG4xbVHLIs6-atmhd4bDARLeLoPpt47UnjfU130_assertion description "[The results from this study suggest, however, that the expression of survivin, survivin-deltaEx3, survivin-2B, bag-1, galectin-3, bax-alpha and MRP-1 mRNAs cannot be considered as prognostic indicators of disease outcome for patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419867.RAAn_ry4RWG4xbVHLIs6-atmhd4bDARLeLoPpt47UnjfU130_provenance.
- NP419874.RAw3tqetfvmJvMJbvSofJH96fWlRaCWkL5f4cZ8HjwTEg130_assertion description "[The results from this study suggest, however, that the expression of survivin, survivin-deltaEx3, survivin-2B, bag-1, galectin-3, bax-alpha and MRP-1 mRNAs cannot be considered as prognostic indicators of disease outcome for patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419874.RAw3tqetfvmJvMJbvSofJH96fWlRaCWkL5f4cZ8HjwTEg130_provenance.